Peer-Reviewed Medical Journal
Appears in 1 story · Last updated Sep 8, 2026
As of September 2026: Publication venue for the study
Some prostate cancer tumors survive treatment by changing what they are—losing glandular identity and adopting stem-cell-like traits, a process called transdifferentiation. A University of Michigan team showed in JCI Insight that combining two drug classes reverses many of those changes and sharply slows tumor growth in mice.
Updated Sep 8
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
